Friday, January 28, 2022: Life Sciences

Biogen Inc. will sell its nearly 50 percent stake in Samsung Bioepis, a joint venture with Samsung Biologics to develop biosimilar drugs, to its partner for at least $2.25 billion. The deal will give Biogen access to $1 billion in cash upon closing as the pharma...

Thursday, January 27, 2022: Payers

During a recent webinar, Third Horizon Strategies Managing Director Cheryl Matochik discussed what the employee benefits industry can expect to see in 2022. Cheryl stated that the industry is “moving toward a completely new standard of personalized benefits.” She, and...

Thursday, January 27, 2022: Mental Health

Numerous reports and studies have highlighted the importance of employers offering mental health support to employees. Doing so not only increases employee engagement and productivity, but reduces direct and indirect costs. A new blog authored by Cheryl Matochik...